John Balk, DO
Orthopaedic Surgery · Lorain, OHNPI 1215371562
Payments from drug & device makers
Across 100 payments — averaging $189.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$8K
- Medacta USA, Inc.$6K
- Seaspine Orthopedics Corporation$2K
- Aesculap Implant Systems, LLC$1K
- Rock Medical Orthopedics, Inc.$813
- Si-bone, Inc.$806
- plus $1K from 18 others
What the payments were for
- Grants$7,50040%
- Travel & lodging$8,63046%
- Food & beverage$2,00411%
- Education$7944%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical(2 entities) | 2 | $7,523 |
| Medacta USA, Inc. | 29 | $5,816 |
| Seaspine Orthopedics Corporation | 7 | $1,629 |
| Aesculap Implant Systems, LLC | 10 | $1,101 |
| Rock Medical Orthopedics, Inc. | 2 | $813 |
| Si-bone, Inc. | 6 | $806 |
| Amgen(2 entities) | 11 | $270 |
| Spineology Inc. | 2 | $188 |
| Orthofix Medical, Inc. | 2 | $161 |
| Johnson & Johnson | 1 | $112 |
| Jazz Pharmaceuticals Inc. | 5 | $80 |
| AbbVie | 4 | $78 |
| Conformis, Inc. | 1 | $73 |
| Bioventus LLC | 2 | $40 |
| Merck | 3 | $37 |
| Biohaven Pharmaceuticals, Inc. | 2 | $34 |
| Heron Therapeutics, Inc. | 2 | $31 |
| Novo Nordisk | 2 | $30 |
| Pacira Therapeutics, Inc. | 2 | $27 |
| Abbott | 1 | $19 |
| Theragen, Inc. | 1 | $18 |
| Trevena, Inc. | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GMK SPHERE$2,322
- AMISTEM$1,348
- MYSPINE$1,093
- Regatta$911
- Laminoplasty$911
- iFuse Implant$733
- ACTIVL$715
- PRIMARY SHOULDER$672
- Vu aPOD Prime NanoMetalene$663
- ASCENT;ASCENT LE;FIREBIRD SFS;ICON SFS;SFS$148
- EVENITY$121
- XARELTO$112
- OPTIMESH EXPANDABLE INTERBODY FUSION SYSTEM$112
How this compares
$18,928 in reported general payments places this provider in the 80th percentile of 794 orthopaedic surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TymlosAbaloparatide | 16 | $43,015 |
| Methylprednisolone | 35 | $281 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 31 | $254 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $114 |
| Oxycodone Hcl | 14 | $86 |
| Gabapentin | 18 | $67 |
| Tramadol Hcl | 30 | $64 |
| Ibuprofen | 13 | $54 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Lorain
- Reuben GobezieCleveland$12.6M
- Brad PichaIndependence$12.3M
- Gregory BerletWorthington$9.9M
- Wael BarsoumCleveland$8.9M
- Brian CohenChillicothe$8.9M
- Joseph IannottiCleveland$7.1M
- John SontichYoungstown$3.6M
- Anthony MiniaciCleveland$3.1M
- Mark FroimsonCleveland$2.9M
- David WelkerMiamisburg$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.